Moss Beach, CA, United States of America

James Q Oeswein

USPTO Granted Patents = 13 

Average Co-Inventor Count = 3.0

ph-index = 11

Forward Citations = 1,061(Granted Patents)


Location History:

  • Montara, CA (US) (1992)
  • El Granada, CA (US) (1995)
  • Moss Beach, CA (US) (1994 - 2007)

Company Filing History:


Years Active: 1992-2007

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations of James Q Oeswein: A Pioneer in Pharmaceutical Patents

Introduction

James Q Oeswein, an accomplished inventor based in Moss Beach, California, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 13 patents, he continues to push the boundaries of innovation in the industry, focusing on formulations that enhance therapeutic efficacy.

Latest Patents

Among his notable inventions, two recent patents stand out. The first is a formulated composition that comprises a mixture of polypeptides of opposite charge and an excipient selected from arginine, lysine, glutamic acid, sodium dodecyl sulfate, beta-hydroxy cyclodextrin, and beta-cyclodextrin sulfobutyl ether. This innovative approach may lead to advancements in drug formulation techniques. The second patent involves an antibody formulation, detailing a stable aqueous pharmaceutical formulation that comprises a therapeutically effective amount of antibody not subjected to prior lyophilization, alongside a buffer maintaining the pH in the range of about 4.5 to about 6.0, a surfactant, and a polyol. This formulation opens new avenues for therapeutic applications and stability in pharmaceutical products.

Career Highlights

James Q Oeswein is currently associated with Genentech, Inc., a leading biotechnology company known for its pioneering work in drug development. His tenure at Genentech has been marked by a commitment to innovation, enabling him to leverage his expertise in creating groundbreaking pharmaceutical formulations.

Collaborations

Throughout his career, Oeswein has collaborated with talented professionals, including his coworkers Douglas A Yeung and Sharon X Wang. These collaborations not only enrich his work but also foster a synergistic environment for developing novel solutions in biotechnology.

Conclusion

James Q Oeswein exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only reflect his expertise but also contribute significantly to advancements in drug formulation and therapeutic efficacy. As he continues his work at Genentech, Oeswein's inventions are poised to have a lasting impact on healthcare and patient treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…